Stem cell research news from FierceBiotech
NewsFDA's delay of Geron ESC trial raises concerns
Getting an embryonic stem cell therapy through clinical trials in the U.S. is looking like an increasingly tough challenge after Geron announced that the FDA is delaying a study of its experimental Read more...
California grants ignite a boom of lab construction
After four years of litigation and detailed planning, the first $271 million in facilities grants is just about ready to be doled out by the Read more...
San Diego institutes plan $115M stem cell lab
Four of San Diego's biggest research institutions are teaming up to form the San Diego Consortium for Regenerative Medicine, a group aimed at advancing stem cell work. The four research Read more...
What's in store for stem cell treatments?
At yesterday's hearing on stem cells, the FDA set a high bar for the treatments, saying Read more...
Stem cell developers shift focus to FDA hearings
Everyone involved in embryonic stem cell programs will be paying close attention to hearings the FDA is holding on how they plan to regulate the field. Developers want a much clearer idea of the Read more...
Sanofi makes moves in China
In the Wall Street Journal, Sanofi's R&D chief Marc Cluzel (photo) Read more...
Stem cell institute in wrangle over office costs
California's stem cell institute says the property management company that promised to underwrite all their office operating costs in San Francisco appears to be reneging on the deal, and they're Read more...
Stem cell outfits a winner in upcoming election
The nation's top biotech analysts have looked over the field of presidential candidates and announced a big winner: Stem cell companies. Read more...
ALSO NOTED: Manhattan Pharma closes JV deal; Abbott, Genentech, WEHI in cancer collaboration; and much more...
> Manhattan Pharmaceuticals has closed on its joint venture agreement with Nordic Biotech Venture Fund II K/S to develop and commercialize Hedrin for head lice for the North American market. Read more...
ALSO NOTED: North Carolina steps up biotech funding; Petra Group plots start-up; ProMetic in development deal; and much more...
> North Carolina lawmakers have boosted their support of the biotech field, adding $83 million to support research, training and manufacturing initiatives. Read more...
| Press ReleasesPRESS RELEASE: Stem Cells Improve Heart Function After Heart Attack GERON SCIENTISTS AND COLLABORATORS DEMONSTRATE HUMAN EMBRYONIC STEM CELL-DERIVED CARDIOMYOCYTES IMPROVE HEART FUNCTION WHEN TRANSPLANTED AFTER MYOCARDIAL INFARCTION Landmark Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends